Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating activities
Net income	$ 26,126	$ 17,117
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	3,415	3,074
Stock-based compensation expense	1,685	3,534
Inventory impairment and other	781
Deferred income taxes	(521)	172
Loss on disposition of assets	330	358
Changes in assets and liabilities:
Cash held in escrow	12,811	(320)
Accounts receivable	4,349	1,028
Inventories	(60,930)	(69,106)
Prepaid expenses and other assets	2,000	(2,659)
Accounts payable	(44,624)	(15,831)
Accrued expenses and other liabilities	(1,198)	(11,296)
Mortgage loans held for sale	43,400	14,529
Net cash used in operating activities	(12,376)	(59,400)
Investing activities
Purchases of property and equipment	(2,686)	(3,270)
Other investing activities	59	(14)
Net cash used in investing activities	(2,627)	(3,284)
Financing activities
Borrowings under revolving credit facilities	678,000	288,800
Payments on revolving credit facilities	(224,800)	(204,300)
Principal payments on notes payable	(2,043)	(7,716)
Proceeds from insurance notes payable	4,137	9,301
Net proceeds from mortgage repurchase facilities	(40,302)	(13,689)
Repurchases of common stock upon vesting of stock-based compensation	(4,977)	(3,166)
Repurchases of common stock under stock repurchase program		(1,439)
Net cash provided by financing activities	410,015	67,791
Net increase	395,012	5,107
Cash and cash equivalents and Restricted cash, Beginning of period	58,522	36,441
Cash and cash equivalents and Restricted cash, End of period	453,534	41,548
Supplemental cash flow disclosure
Cash paid for income taxes
Cash and cash equivalents and Restricted cash
Cash and cash equivalents	450,973	38,115
Restricted cash (Note 5)	$ 2,561	$ 3,433